Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10533186
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
granted -
US 10533227
Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
granted -
US 10526400
Humanized pertussis antibodies and used thereof
granted -
US 10519247
Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
granted -
US 10519188
Cyclic di-nucleotide compounds and methods of use
granted -
US 10519205
Compositions and methods for use of anion channel rhodopsins
granted -
US 10517948
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 10508129
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10500256
Polymers for delivery of therapeutic proteins
granted -
US 10501490
Taccalonolide microtubule stabilizers
granted -
US 10501575
Biomimetic fluoroscopic films
granted -
US 10501538
Anti-LILRB antibodies and their use in detecting and treating cancer
granted -
US 10493162
Somatostatin receptor-based cancer therapy
granted -
US 10478485
Methods and compositions to prevent or treat bacterial infections
granted -
US 10479825
Antibody-mediated neutralization of Marburg virus
granted -
US 10471109
Compositions and methods for promoting nitric oxide production through an oral delivery system
granted -
US 10465227
Microbial testing devices, methods of making microbial testing devices and methods of identifying novel antimicrobial drug candidates
granted -
US 10463685
Telomerase mediated telomere altering compounds
granted -
US 10463684
Nucleobase analogue derivatives and their applications
granted -
US 10464994
Recombinant clusterin and use thereof in the treatment and prevention of disease
granted -
US 10457662
Substituted amides for treating and preventing cancer
granted -
US 10457676
Capsazepine analogs for the treatment of cancer and other proliferative diseases
granted -
US 10450275
Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
granted -
US 10450352
Engineered polypeptides for antigen delivery
granted